VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,091,000 | -19.5% | 46,929 | -44.9% | 0.47% | -6.7% |
| Q1 2018 | $1,356,000 | +513.6% | 85,200 | +326.0% | 0.51% | +614.1% |
| Q1 2017 | $221,000 | -59.8% | 20,000 | -10.7% | 0.07% | -65.2% |
| Q3 2016 | $550,000 | -31.9% | 22,400 | -44.1% | 0.20% | -24.4% |
| Q2 2016 | $808,000 | +127.6% | 40,100 | +197.0% | 0.27% | +134.8% |
| Q1 2016 | $355,000 | -55.2% | 13,500 | +73.1% | 0.12% | -56.6% |
| Q4 2015 | $793,000 | -61.3% | 7,800 | -32.2% | 0.26% | -61.3% |
| Q3 2015 | $2,051,000 | -54.1% | 11,500 | -42.8% | 0.68% | -48.0% |
| Q2 2015 | $4,465,000 | +2.2% | 20,100 | -8.6% | 1.32% | -8.7% |
| Q1 2015 | $4,370,000 | +59.0% | 22,000 | +14.6% | 1.44% | +34.0% |
| Q4 2014 | $2,748,000 | – | 19,200 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |